Dihydroartemisinin Induces Ferroptosis in Ovarian Cancer via STAT3/GPX4 Signaling Pathway
Chinese Journal of Integrative Medicine · 2026-05 · 32 (5) · 415-422
DOI: 10.1007/s11655-026-4244-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, online erschienen am 01.04.2026. Verfasst von Lu Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu Province, 225001, C…. Hauptthemen laut MEDLINE: Artemisinins, Ferroptosis, Ovarian Neoplasms, STAT3 Transcription Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To investigate the effects and underlying mechanism of action of dihydroartemisinin (DHA) on ferroptosis in ovarian cancer (OC). METHODS: In vitro, SKOV3 and A2780 cells were treated with different concentrations of DHA. The proliferative capacity of DHA-treated OC cells was determined using cell counting kit-8 assay, scratch test and clone formation assay. In addition, OC cells were treated with the ferroptosis inhibitor (ferrostatin-1; Fer-1) in combination with DHA to observe the changes in cell viability. To confirm the oxidative stress-inducing effect of DHA, levels of Fe2+, glutathione (GSH) and reactive oxygen species (ROS) were detected using Fe2+, GSH and ROS kits, respectively. Western blotting and quantitative PCR analyses were performed to detect the expressions of signal transducer and activator of transcription 3 (STAT3), recombinant solute carrier family 7 member 11 (SLC7A11), and glutathione peroxidase 4 (GPX4) at the protein and gene expression levels to determine stimulatory effects on ferroptosis. In vivo, in accordance with the random number table approach, nude mice with successful tumor loading were divided into vehicle and DHA (150 mg/kg) groups, with 3 mice in each group. Throughout the 10-day treatment period, the body weights and tumor volumes of the mice were documented. The STAT3, SLC7A11, and GPX4 protein expression levels were determined using Western blotting and immunohistochemistry, respectively. RESULTS: DHA significantly reduced the viability of OC cells, and treatment with Fer-1 significantly increased the survival rate of OC cells (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu Province, 225001, China. ludan1968@126.com.
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu Province, 225001, China. ludan1968@126.com.
- Department of Gynaecology and Obstetrics, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu Province, 225001, China.
- Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu Province, 225001, China.
Zitieren
APA
Chen, L., Li, Y. Y., Xing, Y., Kang, L. Y., & Lu, D. (2026). Dihydroartemisinin Induces Ferroptosis in Ovarian Cancer via STAT3/GPX4 Signaling Pathway. Chinese Journal of Integrative Medicine, 32(5), 415-422. https://doi.org/10.1007/s11655-026-4244-3
Vancouver
Chen L, Li YY, Xing Y, Kang LY, Lu D. Dihydroartemisinin Induces Ferroptosis in Ovarian Cancer via STAT3/GPX4 Signaling Pathway. Chinese Journal of Integrative Medicine. 2026;32(5):415-422. doi:10.1007/s11655-026-4244-3
BibTeX
@article{Chen2026,
author = {Chen, Lu and Li, You-You and Xing, Yue and Kang, Lu-Yao and Lu, Dan},
title = {Dihydroartemisinin Induces Ferroptosis in Ovarian Cancer via STAT3/GPX4 Signaling Pathway},
journal = {Chinese Journal of Integrative Medicine},
year = {2026},
volume = {32},
number = {5},
pages = {415--422},
doi = {10.1007/s11655-026-4244-3}
}
EUVIMED